Cagrilintide (5mg / 10mg) Research Peptide: A Long‑Acting Dual Amylin & Calcitonin Receptor Agonist for Metabolic Studies

If your research explores the non‑incretin pathways of satiety signalling, energy balance, or the next generation of obesity therapeutics, Cagrilintide (5mg / 10mg) research peptide — also known as AM833 — offers a precisely defined and mechanistically distinct synthetic tool. Cagrilintide is a long‑acting, lipidated analogue of the pancreatic hormone amylin engineered as a dual amylin and calcitonin receptor agonist (DACRA).

It binds non‑selectively to amylin receptors (AMY1R, AMY2R, AMY3R) and the calcitonin receptor (CTR), activating Gs‑coupled signalling pathways that induce satiety and reduce food intake through the dorsal vagal complex (DVC) of the brainstem. This distinct mode of action — separate from GLP‑1‑based therapies — positions Cagrilintide (5mg / 10mg) research peptide as a valuable tool for laboratories investigating metabolic regulation, obesity pathophysiology, and the neural circuits that control feeding behaviour.

At Chinese Grey Peptides, we supply high‑purity Cagrilintide (5mg / 10mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to >99% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into metabolic regulation, satiety signalling, and obesity research begin with uncompromising quality.

What Is Cagrilintide and How Does It Work?

To fully appreciate the research potential of Cagrilintide (5mg / 10mg) research peptide, it is essential to understand its biochemical design and the precise mechanisms by which it exerts its pleiotropic metabolic effects.

The Lipidated Amylin Analogue

Cagrilintide (AM833) is a long‑acting, lipidated analogue of the pancreatic hormone amylin. As a non‑selective agonist of the calcitonin family of G protein‑coupled receptors — a class of receptors that includes the amylin receptor (AMYR) and the calcitonin receptor (CTR) — cagrilintide represents a distinct class of metabolic research tools. It has demonstrated efficacy for the treatment of obesity in phase 2 clinical trials.

Mechanism of Action: Dual Amylin & Calcitonin Receptor Agonism (DACRA)

The biological activity of Cagrilintide (5mg / 10mg) research peptide is mediated through its non‑selective activation of amylin and calcitonin receptors:

• Receptor Binding: Cagrilintide binds to amylin receptors (AMY1R, AMY2R, AMY3R) and the calcitonin receptor (CTR) with high affinity. AMYRs are heterodimers of the CTR and receptor activity‑modifying proteins (RAMPs). Cagrilintide has an amylin‑like binding mode but, compared to other peptides, induces distinct conformational dynamics at calcitonin‑family receptors that could contribute to its clinical efficacy.

• Gs‑Protein Signalling: Receptor activation stimulates Gs‑protein signalling, increasing intracellular cAMP levels.

• Neural Mediation of Energy Balance: Cagrilintide exerts its effects on energy balance through the dorsal vagal complex (DVC) of the brainstem. Long‑term treatment upregulates prolactin‑releasing hormone (Prlh) expression in Calcr/Prlh neurons of the nucleus of the solitary tract — a conserved mechanism across rodents, macaques, and humans.

• Distinct Pharmacological Profile: Cagrilintide has a unique pharmacological profile across diverse measures of receptor binding, activation, and regulation when compared with other selective and non‑selective calcitonin receptor and amylin receptor agonists.

Research Note: A Non‑Incretin Pathway for Obesity Research

Unlike GLP‑1 receptor agonists such as semaglutide and tirzepatide, which target incretin pathways, cagrilintide acts through the amylin system — a pancreatic hormone that induces satiety. This distinct mode of action makes it a valuable tool for studying complementary pathways in metabolic regulation. Endogenous amylin is co‑secreted with insulin from pancreatic beta cells, and while amylin acts via the amylin receptor (a complex of CALCR and one of three RAMPs), cagrilintide binds the amylin receptor and CALCR with similar potency.

Key Research Applications for Cagrilintide (5mg / 10mg)

Cagrilintide (5mg / 10mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.

1. Obesity & Weight Regulation Research

Cagrilintide has demonstrated robust, dose‑dependent weight loss in clinical and preclinical models. Research applications include:

• Energy Balance Studies: Investigating the neural circuits and molecular mechanisms through which amylin receptor activation reduces food intake.

• Satiety Signalling Pathways: Exploring how cagrilintide modulates the activity of Calcr‑expressing neurons in the dorsal vagal complex.

• Combination Studies: The combination of cagrilintide and semaglutide (CagriSema) produces 22.7% weight loss over 68 weeks versus 16.1% for semaglutide alone.

• Dose‑Response Studies: Characterising the dose‑dependent effects of cagrilintide on food intake and body weight.

2. Metabolic & Diabetes Research

Cagrilintide is being investigated for its broader metabolic effects:

• Type 2 Diabetes Research: Cagrilintide is in clinical development for weight management and type 2 diabetes in a fixed‑dose combination with semaglutide.

• Glycaemic Control: Studying the effects of amylin receptor activation on glucose homeostasis and insulin sensitivity.

• Metabolic Disease Research: Cagrilintide (Cagri), functioning as a DACRA, demonstrates significant efficacy in obesity treatment and associated metabolic disorders.

3. Neuroscience & Brain‑Gut Axis Research

Cagrilintide’s effects on the dorsal vagal complex make it a valuable tool for studying the neural control of feeding:

• Brainstem Circuitry: Investigating how cagrilintide modulates neuronal populations in the area postrema and nucleus of the solitary tract.

• Prlh Signalling: Studying the role of prolactin‑releasing hormone in mediating the effects of amylin receptor agonists.

• Cross‑Species Conservation: Exploring conserved neural mechanisms of energy balance regulation across rodents, macaques, and humans.

4. Receptor Pharmacology & Structural Biology

As a well‑characterised DACRA, cagrilintide serves as a molecular probe for studying receptor pharmacology:

• Receptor Binding Assays: Characterising the affinity and selectivity of cagrilintide for AMYRs and CTR.

• Signal Transduction Studies: Dissecting the Gs‑protein signalling pathways activated by dual receptor engagement.

• Cryo‑EM Structural Studies: Using cagrilintide as a tool to elucidate receptor complex structures.

5. Combination & Add‑On Therapy Research

Cagrilintide is being investigated in multiple combination contexts:

• CagriSema (Cagrilintide + Semaglutide): In the REDEFINE 4 trial, CagriSema achieved 23.0% weight loss at 84 weeks.

• Add‑On to Basal Insulin: Cagrilintide–semaglutide provided bodyweight reductions of 10–12% as an add‑on to basal insulin in adults with type 2 diabetes.

Chemical & Physical Specifications for Cagrilintide (5mg / 10mg)

Accurate characterisation of Cagrilintide (5mg / 10mg) research peptide is essential for reproducible experimental design.

Note: The 5 mg and 10 mg masses refer to the weight of the peptide in its lyophilised form. Cagrilintide is a research peptide. Not for human consumption. Cagrilintide is not FDA‑approved for therapeutic use.

Reconstitution & Handling Protocol for Cagrilintide

Proper reconstitution of Cagrilintide (5mg / 10mg) research peptide is critical for maintaining its structural integrity and biological activity.

Step 1 – Preparation

• Bring the sealed Cagrilintide vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the Cagrilintide vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 5 mg or 10 mg per 1 mL of diluent, yielding a 5‑10 mg/mL stock solution.

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted Cagrilintide into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles, as peptides are susceptible to degradation.

• Once thawed, store at 2‑8°C and use within a short period.

Concentration Reference Table for Cagrilintide (5mg / 10mg)

Adjust diluent volume based on your experimental requirements. For cell culture applications, typical working concentrations may range from 0.1‑10 µM.

Storage & Stability Guidelines for Cagrilintide (5mg / 10mg)

Why Choose Chinese Grey Peptides for Cagrilintide (5mg / 10mg)?

As an authentic licensed peptide supplier based in the USA, we supply Cagrilintide (5mg / 10mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed >99% for every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO). Cagrilintide is not FDA‑approved for therapeutic use.

Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: Cagrilintide (5mg / 10mg) Research Peptide

What is Cagrilintide (5mg / 10mg) research peptide?
Cagrilintide (AM833) is a long‑acting, lipidated analogue of the pancreatic hormone amylin. It is a dual agonist of amylin receptors (AMY1R, AMY2R, AMY3R) and the calcitonin receptor (CTR), functioning as a DACRA (dual amylin and calcitonin receptor agonist). It is used in research to study satiety, energy balance, and obesity.

What is the mechanism of action of Cagrilintide?
Cagrilintide binds non‑selectively to amylin receptors and the calcitonin receptor, activating Gs‑protein signalling and increasing intracellular cAMP. It modulates energy balance through neural pathways in the dorsal vagal complex (DVC) of the brainstem, upregulating prolactin‑releasing hormone (Prlh) expression in conserved neuronal populations.

 What are the primary research applications for Cagrilintide?
Cagrilintide is used in obesity and weight regulation research (energy balance studies, satiety signalling), metabolic and diabetes research (type 2 diabetes, glycaemic control), neuroscience and brain‑gut axis research (brainstem circuitry, Prlh signalling), receptor pharmacology and structural biology, and combination therapy research (CagriSema).

 What clinical trial data support Cagrilintide’s efficacy?
Cagrilintide monotherapy induces 11.8% weight loss over 68 weeks. Cagrilintide combined with semaglutide (CagriSema) produces 22.7% weight loss over 68 weeks versus 16.1% for semaglutide alone. In REDEFINE 4, CagriSema achieved 23.0% weight loss at 84 weeks.

What purity does your Cagrilintide (5mg / 10mg) meet?
Our Cagrilintide is tested to >99% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

How should I reconstitute Cagrilintide (5mg / 10mg)?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. A typical starting concentration is 10 mg/mL.

How should I store reconstituted Cagrilintide?
Reconstituted Cagrilintide should be stored at 2‑8°C for short‑term use. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

 Is Cagrilintide research peptide legal to purchase in the USA?
Yes. Cagrilintide is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: Cagrilintide is not FDA‑approved for therapeutic use and is supplied for research purposes only.

Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.

Cagrilintide (5mg / 10mg)

1. Shop Page
2. Bulk Orders Page
3. Contact Page
4. Shipping & Return Page
5. Peptide Purity Page

• PubChem Cagrilintide
• FDA GSRS Cagrilintide
• Novo Nordisk CagriSema filing notice
• FDA Summit Research Peptides warning letter
• Google Merchant Listing Structured Data
• Rank Math WooCommerce Product Schema

Cagrilintide (5mg / 10mg)

Ships to USA, Canada, UK & Europe

Chinese Grey Peptides supports shipping to the USA, Canada, the United Kingdom, France, Germany, Spain, Sweden, Italy, and Europe where permitted.

Shipping support may include:

• Order processing updates
• Packaging support
• Tracking information where available
• Wholesale shipment planning
• Destination-based shipping review
• Customer support during transit

Shipping times may vary by order size, carrier, destination, customs process, product status, and local requirements.

Why Choose Chinese Grey Peptides?

Chinese Grey Peptides focuses on quality, support, and clear communication. We help buyers review product details before placing an order.

Customers choose us for:

• Professional peptide supplier support
• Small and wholesale order options
• Product documentation support
• HPLC testing information where available
• Mass Spectrum documentation where available
• International shipping support
• Responsive communication
• Clear order assistance before payment

We aim to make the buying process transparent, professional, and documentation-focused.

Important Compliance Notice

Cagrilintide 5mg 10mg may be regulated differently depending on the country, product type, labeling, intended use, buyer type, and destination. Chinese Grey Peptides does not provide medical advice, dosing instructions, injection guidance, weight-management claims, obesity claims, glucose claims, diabetes claims, appetite claims, metabolic claims, body-composition claims, fat-loss claims, disease claims, treatment claims, or personal-use recommendations.

Customers are responsible for understanding and following all local laws, import rules, prescription requirements, compounding rules, sport-governing rules, labeling rules, and permitted-use requirements before ordering.

From its design as a long‑acting, lipidated amylin analogue to its well‑characterised role as a dual agonist of amylin and calcitonin receptors, Cagrilintide (5mg / 10mg) research peptide provides a precisely defined and mechanistically distinct platform for advanced metabolic research.

Cagrilintide (5mg / 10mg)

Its ability to activate Gs‑signalling pathways, modulate energy balance through the dorsal vagal complex, and induce significant weight loss through satiety signalling—supported by peer‑reviewed research published in Nature Metabolism, Nature Communications, the New England Journal of Medicine, and other authoritative journals—makes it a valuable addition to any laboratory investigating obesity pathophysiology, satiety signalling, or the neural circuits that control feeding behaviour. By choosing high‑purity, lab‑verified Cagrilintide (5mg / 10mg) research peptide from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with Cagrilintide (5mg / 10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade Cagrilintide delivered directly to your facility in the USA, UK, or Europe.